Constructive Bio

Life, reimagined.

Cambridge, United Kingdom · Founded 2021 · $73.0M raised

Headquarters
Cambridge
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$73.0M
Last Round
$58.0M Series ASep 2024
Rounds
2

About

Constructive Bio is a Cambridge-based synthetic genomics company spun out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology. The company uses the world's first fully synthetic recoded organism to produce therapeutics with chemistries that natural biology cannot access, combining de-novo genome synthesis with engineered translation. Its platform enables the incorporation of non-canonical amino acids into peptides and proteins at scale, unlocking new classes of enzymes, pharmaceuticals, and biomaterials. Constructive Bio's technology is built on peer-reviewed science published in Nature, Science, and Nature Chemistry.

Summary

Constructive Bio is a Biotech company based in Cambridge, United Kingdom, founded in 2021. It has raised $73.0M in total across 2 rounds, most recently a $58.0M Series A round in Sep 2024. Investors include Ahren Innovation Capital, OMX Ventures and Paladin Capital Group.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2024
$58.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Constructive Bio on Indexed.vc
<a href="https://indexed.vc/companies/constructive-bio"><img src="https://indexed.vc/api/badge/company/constructive-bio" alt="Constructive Bio on Indexed.vc" width="260" height="76" /></a>